Delivering Innovations to Patients In Need
Innovations in drug delivery systems
Discover Pleryon
Pleryon is a drug delivery platform company dedicated to improving the standard of living across the global community by developing programs utilizing advanced drug delivery technologies. Pleryon's platform is supported by pillar technologies covers a broad spectrum of molecules and therapeutic areas.
Versatile
Cargo Scale
from small molecules to nucleic acidBroad
Biological Scale
from subcellular to tissue levelTunable
Time Scale
from hours tomonthsMeet Members of Pleryon
Yu YU, Ph.D.
Cofounder, Chairman of the Board and CEO
Dr. Yu Yu is an inventor and entrepreneur in drug delivery and biomaterial. He has over 14 years experience in biomaterials innovations. He is the key inventor for more than 10 invention disclosures and filed for more than 40 patent applications with inventions licensed to multiple companies. He also has published 11 research articles with more than 320 citation and a hi-index of 9.Dr. Yu received his BSc in Biology and PhD in Bioengineering (Laboratory of Ying Chau) from the Hong Kong University of Science and Technology (HKUST), and was awarded Overseas High-Caliber Personnel by Shenzhen government.Prof. Ying CHAU, Ph.D.
Cofounder, Board member and consulting scientist
Prof. Ying Chau is a leading expert in drug delivery and biomaterials in China. She is a Professor of Chemical and Biological Engineering and Director of Bioengineering Program at the Hong Kong University of Science and Technology. She is also the Vice Chairman of Hong Kong Biotech Association (HKBIO). Prof. Chau has more than 25 years academic and industry experience, and has published 60 research articles with more than 2000 citations.Prof. Chau received her B.S from Cornell University, M.S from University of Pennsylvania, and PhD from MIT (Laboratory of Robert Langer).Andrew LUK, Ph.D.
Executive Director of Global Alliance
Dr. Andrew Luk brings 27 years medtech industry experience to Pleryon. Before joining Pleryon, Dr. Luk held senior positions in CooperVision Inc. and Johnson & Johnson, where he had extensive product development, technology translation and collaborative alliance experiences. He has been involved in advancing innovative products from concepts to clinical trials (including regulatory submission) for a variety of drug delivery, drug-device combination products and medical devices, with excellent knowledge in quality assurance and regulatory compliance. Dr. Luk received his PhD in Chemical Engineering from University of Delaware.Zhexun SUN, Ph.D.
Director of Innovation and Chemistry
Dr. Sun Zhexun has over 10 years academic experience in biotherapeutic polymer design and engineering. Before joining Pleryon, he is a postdoctoral fellow at Cornell University, designing innovative polymers for orthopedics and ophthalmic applications.Dr. Sun received his B.S from Wuhan University, M.S from Rutgers University and Cornell University, and PhD from Cornell University (Laboratory of David Putnam). He received Cornell Engineering Scale-up Award and was awarded Overseas High-Caliber Personnel by Shenzhen government.Contact us
Longhua and HK-SZ Collaboration ZoneZhangjiang High Tech Park (JLABS@Shanghai) contact [at] pleryon.com
Get Pleryon's latest News from our WeChat public account!
Pleryon Therapeutics 科凝生物制药
Innovations in biofunctional polymers
https://user-assets.sxlcdn.com/images/212758/FtJGpNfcTlKqpkvxutYZeGsNyiIs.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/quality/90!/format/png